168 related articles for article (PubMed ID: 10766693)
1. Rapid-onset subfulminant liver failure associated with troglitazone.
Jagannath S; Rai R
Ann Intern Med; 2000 Apr; 132(8):677. PubMed ID: 10766693
[No Abstract] [Full Text] [Related]
2. Hepatotoxicity of the thiazolidinediones.
Tolman KG; Chandramouli J
Clin Liver Dis; 2003 May; 7(2):369-79, vi. PubMed ID: 12879989
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone-associated hepatic failure.
Misbin RI
Ann Intern Med; 1999 Feb; 130(4 Pt 1):330. PubMed ID: 10068399
[No Abstract] [Full Text] [Related]
4. Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone.
Graham DJ; Drinkard CR; Shatin D
Am J Gastroenterol; 2003 Jan; 98(1):175-9. PubMed ID: 12526954
[TBL] [Abstract][Full Text] [Related]
5. Hepatic injury due to troglitazone.
Malik AH; Prasad P; Saboorian MH; Thiele DL; Malet PF
Dig Dis Sci; 2000 Jan; 45(1):210-4. PubMed ID: 10695637
[No Abstract] [Full Text] [Related]
6. Fatal hepatotoxicity associated with troglitazone.
Vella A; de Groen PC; Dinneen SF
Ann Intern Med; 1998 Dec; 129(12):1080. PubMed ID: 9867776
[No Abstract] [Full Text] [Related]
7. Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone.
Gitlin N; Julie NL; Spurr CL; Lim KN; Juarbe HM
Ann Intern Med; 1998 Jul; 129(1):36-8. PubMed ID: 9652997
[No Abstract] [Full Text] [Related]
8. Troglitazone-associated hepatic failure.
Booth AM; Caldwell SH; Iezzoni JC
Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
[No Abstract] [Full Text] [Related]
9. Substituting for troglitazone (Rezulin).
Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
[No Abstract] [Full Text] [Related]
10. Late-onset troglitazone-induced hepatic dysfunction.
Bell DS; Ovalle F
Diabetes Care; 2000 Jan; 23(1):128-9. PubMed ID: 10857986
[No Abstract] [Full Text] [Related]
11. A Japanese case of liver dysfunction after 19 months of troglitazone treatment.
Iwase M; Yamaguchi M; Yoshinari M; Okamura C; Hirahashi T; Tsuji H; Fujishima M
Diabetes Care; 1999 Aug; 22(8):1382-4. PubMed ID: 10480795
[No Abstract] [Full Text] [Related]
12. Troglitazone-induced liver failure: a case study.
Graham DJ; Green L; Senior JR; Nourjah P
Am J Med; 2003 Mar; 114(4):299-306. PubMed ID: 12681458
[TBL] [Abstract][Full Text] [Related]
13. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
Lenhard MJ; Funk WB
Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
[No Abstract] [Full Text] [Related]
14. Severe but reversible hepatitis induced by troglitazone.
Schiano T; Dolehide K; Hart J; Baker AL
Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
[No Abstract] [Full Text] [Related]
15. Troglitazone (Rezulin) and hepatic injury.
Faich GA; Moseley RH
Pharmacoepidemiol Drug Saf; 2001; 10(6):537-47. PubMed ID: 11828837
[TBL] [Abstract][Full Text] [Related]
16. FDA reviews troglitazone.
Donnelly R
Diabetes Obes Metab; 1999 Mar; 1(2):65-6. PubMed ID: 11220513
[No Abstract] [Full Text] [Related]
17. Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings.
Li H; Heller DS; Leevy CB; Zierer KG; Klein KM
J Diabetes Complications; 2000; 14(3):175-7. PubMed ID: 10989325
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone-induced hepatic failure leading to liver transplantation. A case report.
Neuschwander-Tetri BA; Isley WL; Oki JC; Ramrakhiani S; Quiason SG; Phillips NJ; Brunt EM
Ann Intern Med; 1998 Jul; 129(1):38-41. PubMed ID: 9652998
[TBL] [Abstract][Full Text] [Related]
19. Avoiding hepatic injury from drugs.
Kaplowitz N
Gastroenterology; 1999 Oct; 117(4):759. PubMed ID: 10500055
[No Abstract] [Full Text] [Related]
20. Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group.
Murphy EJ; Davern TJ; Shakil AO; Shick L; Masharani U; Chow H; Freise C; Lee WM; Bass NM
Dig Dis Sci; 2000 Mar; 45(3):549-53. PubMed ID: 10749332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]